What does AIM ImmunoTech, Inc. do?

Jun 22 2025 06:10 PM IST
share
Share Via
AIM ImmunoTech, Inc. is a micro-cap specialty pharmaceutical company focused on developing immune-enhancing therapies for viral and immune-related disorders. As of March 2025, it reported net sales of $0 million and a net loss of $4 million, with a market cap of $7.76 million.
Overview:
AIM ImmunoTech, Inc. is a specialty pharmaceutical company engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based chronic disorders, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025)
Market cap: USD 7.76 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 1,694.08%
Debt Equity: 0.02
Return on Equity: 373.68%
Price to Book: -2.01

Contact Details:
Address: 2117 SW Highway 484, OCALA FL: 34473-7949
Tel: ['1 352 4487797', '1 888 5576480']
Fax: 1 352 4804620
Website: https://aimimmuno.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is AIM ImmunoTech, Inc. technically bullish or bearish?
Sep 20 2025 07:13 PM IST
share
Share Via
Who are in the management team of AIM ImmunoTech, Inc.?
Jun 22 2025 10:09 PM IST
share
Share Via
How big is AIM ImmunoTech, Inc.?
Jun 22 2025 05:38 PM IST
share
Share Via